Insights

August 3, 2011 “Financial Independence For The Patent Office” IPLaw360 Robert Gerstein

2011 – Presentation 2011 BIO International Convention, Washington D.C. Panel moderator and speaker on the topic of IP protection for biomarker diagnostics. David Gass

May 2011 “Impact of Recent IP Case law on Biomarkers and Personalized Medicine” Journal of Commercial Biotechnology David Gass

March 29, 2011 “Are Bayh-Dole's Best Days Over?” Law360 Robert Gerstein

2011 – Presentation 2011 Biotechnology and Health-Related Issues Intellectual Property Law Symposium, John Marshall Law School, Chicago Panelist, provided analysis of IP law and strategies for diagnostic and biomarker-based intellectual property in light of recent legal developments, including high profile Supreme Court and Federal Circuit cases such as Bilski, Myriad (AMP v. USPTO), Mayo v. Prometheus, and Classen. David Gass

December 3, 2010 “The Growing Problem of Trademark Registration and Domain Name Scams” IPToday Gregory Chinlund

October 25, 2010 “Covenants Not to Sue In Light of Federal Circuit Decisions” Intellectual Property Litigation Donald W. Rupert

October 1, 2010 “Therasense v. Becton, Dickinson: An Opportunity for the Federal Circuit to Mend Its Fractured Inequitable Conduct Rulings” Co-author, Intellectual Property & Technology Law Journal Donald W. Rupert

March 2010 “Drafting Agreements in the Biotechnology and Pharmaceutical Industries” Oxford University Press Pamela Cox

December 11, 2009 “The Limited Benefits of Product-By-Process Claims” Intellectual Property Today Sandip H. Patel

August 29, 2005 “Incentives to foster new antibiotics are proposed” The National Law Journal Kevin M. Flowers, Ph.D.

Page 3 of 3
Previous